Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management

JS Knight, DW Branch, TL Ortel - bmj, 2023 - bmj.com
Antiphospholipid syndrome (APS) is a thrombo-inflammatory disease propelled by
circulating autoantibodies that recognize cell surface phospholipids and phospholipid …

Antiphospholipid syndrome

LR Sammaritano - Best Practice & Research Clinical Rheumatology, 2020 - Elsevier
Antiphospholipid syndrome is an autoimmune systemic disorder characterized by arterial,
venous, or small vessel thrombosis and/or recurrent early pregnancy loss, fetal loss, or …

Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …

L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …

The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: a comprehensive review

R Cervera, I Rodríguez-Pintó, G Espinosa - Journal of autoimmunity, 2018 - Elsevier
The catastrophic antiphospholipid syndrome (CAPS) is a life-threating variant of the
antiphospholipid syndrome characterized by the development of multiple thrombosis in a …

Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: case series …

N Kello, L El Khoury, G Marder, R Furie… - Seminars in arthritis and …, 2019 - Elsevier
Introduction Thrombotic microangiopathy (TMA) is a life-threatening, albeit infrequent,
complication of systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) …

Microvascular thrombosis: experimental and clinical implications

MA Bray, SE Sartain, J Gollamudi, RE Rumbaut - Translational Research, 2020 - Elsevier
A significant amount of clinical and research interest in thrombosis is focused on large
vessels (eg, stroke, myocardial infarction, deep venous thrombosis, etc.); however …

[PDF][PDF] Study of the efficacy and safety of topical ivermectin+ iota-carrageenan in the prophylaxis against COVID-19 in health personnel

C Héctor, H Roberto, A Psaltis… - J biomed res clin investig, 2020 - bird-group.org
The severe acute respiratory syndrome-coronavirus-2 pandemic has had devastating health
and socio-economic implications worldwide. Epidemiologic data indicate that SARS-CoV2 is …

Immunomodulating therapies in acute myocarditis and recurrent/acute pericarditis

E Ammirati, E Bizzi, G Veronese, M Groh… - Frontiers in …, 2022 - frontiersin.org
The field of inflammatory disease of the heart or “cardio-immunology” is rapidly evolving due
to the wider use of non-invasive diagnostic tools able to detect and monitor myocardial …

Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots

ML Tung, B Tan, R Cherian… - … advances in practice, 2021 - academic.oup.com
As the coronavirus disease 2019 (COVID-19) pandemic, which is caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading rapidly worldwide, it …